Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1998 Feb 1;101(3):613–624. doi: 10.1172/JCI1250

Intracellular trafficking of factor VIII to von Willebrand factor storage granules.

J B Rosenberg 1, P A Foster 1, R J Kaufman 1, E A Vokac 1, M Moussalli 1, P A Kroner 1, R R Montgomery 1
PMCID: PMC508605  PMID: 9449695

Abstract

In plasma, von Willebrand factor (vWf) associates with Factor VIII (FVIII); however, the site at which these proteins first interact has not been defined. Administration of 1-desamino-8-D-arginine vasopressin (DDAVP) causes a rapid, concomitant elevation in plasma levels of both vWf and FVIII, suggesting the existence of a DDAVP-releasable storage pool for both proteins. To determine whether vWf and FVIII can associate intracellularly and colocalize to storage vesicles, we transfected AtT-20 cells with vWf and FVIII expression plasmids. FVIII alone was not detectable within storage granules; however, transfection of vWf cDNA into the same cell caused FVIII to alter its intracellular trafficking and to undergo granular storage, colocalizing to the vWf-containing granules. In contrast, colocalization of FVIII was not observed when these cells were transfected with plasmids encoding defective FVIII-binding vWf mutants. Transfection of bovine endothelial cells with FVIII further demonstrated vesicular storage of FVIII with vWf in Weibel-Palade bodies. Since gene therapy of hemophilia A may ultimately target endothelium or hematopoietic stem cells, the interaction between vWf and FVIII within a secretory cell is important. Thus, vWf can alter the intracellular trafficking of FVIII from a constitutive to a regulated secretory pathway, thereby producing an intracellular storage pool of both proteins.

Full Text

The Full Text of this article is available as a PDF (4.7 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Belloni P. N., Carney D. H., Nicolson G. L. Organ-derived microvessel endothelial cells exhibit differential responsiveness to thrombin and other growth factors. Microvasc Res. 1992 Jan;43(1):20–45. doi: 10.1016/0026-2862(92)90004-9. [DOI] [PubMed] [Google Scholar]
  2. Bontempo F. A., Lewis J. H., Gorenc T. J., Spero J. A., Ragni M. V., Scott J. P., Starzl T. E. Liver transplantation in hemophilia A. Blood. 1987 Jun;69(6):1721–1724. [PMC free article] [PubMed] [Google Scholar]
  3. Burgess T. L., Craik C. S., Kelly R. B. The exocrine protein trypsinogen is targeted into the secretory granules of an endocrine cell line: studies by gene transfer. J Cell Biol. 1985 Aug;101(2):639–645. doi: 10.1083/jcb.101.2.639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Burgess T. L., Kelly R. B. Constitutive and regulated secretion of proteins. Annu Rev Cell Biol. 1987;3:243–293. doi: 10.1146/annurev.cb.03.110187.001331. [DOI] [PubMed] [Google Scholar]
  5. Casonato A., Dannhauser D., Pontara E., Bertomoro A., Orazi B., Santarossa L., Zerbinati P., Girolami A. DDAVP infusion in haemophilia A carriers: different behaviour of plasma factor VIII and von Willebrand factor. Blood Coagul Fibrinolysis. 1996 Jul;7(5):549–553. [PubMed] [Google Scholar]
  6. Cattaneo M., Simoni L., Gringeri A., Mannucci P. M. Patients with severe von Willebrand disease are insensitive to the releasing effect of DDAVP: evidence that the DDAVP-induced increase in plasma factor VIII is not secondary to the increase in plasma von Willebrand factor. Br J Haematol. 1994 Feb;86(2):333–337. doi: 10.1111/j.1365-2141.1994.tb04735.x. [DOI] [PubMed] [Google Scholar]
  7. D'Angelo A., Capitanio A., Smith J. B., Valsecchi C., Mannucci P. M. Effect of des-amino-D-arginine vasopressin (DDAVP) on plasma levels of platelet and endothelial cell release products. Thromb Haemost. 1983 Feb 28;49(1):64–65. [PubMed] [Google Scholar]
  8. Dorner A. J., Kaufman R. J. Analysis of synthesis, processing, and secretion of proteins expressed in mammalian cells. Methods Enzymol. 1990;185:577–596. doi: 10.1016/0076-6879(90)85046-q. [DOI] [PubMed] [Google Scholar]
  9. Dorner A. J., Wasley L. C., Kaufman R. J. Increased synthesis of secreted proteins induces expression of glucose-regulated proteins in butyrate-treated Chinese hamster ovary cells. J Biol Chem. 1989 Dec 5;264(34):20602–20607. [PubMed] [Google Scholar]
  10. Dorner A. J., Wasley L. C., Kaufman R. J. Overexpression of GRP78 mitigates stress induction of glucose regulated proteins and blocks secretion of selective proteins in Chinese hamster ovary cells. EMBO J. 1992 Apr;11(4):1563–1571. doi: 10.1002/j.1460-2075.1992.tb05201.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fallaux F. J., Hoeben R. C., Cramer S. J., van den Wollenberg D. J., Briët E., van Ormondt H., van Der Eb A. J. The human clotting factor VIII cDNA contains an autonomously replicating sequence consensus- and matrix attachment region-like sequence that binds a nuclear factor, represses heterologous gene expression, and mediates the transcriptional effects of sodium butyrate. Mol Cell Biol. 1996 Aug;16(8):4264–4272. doi: 10.1128/mcb.16.8.4264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ginsburg D., Sadler J. E. von Willebrand disease: a database of point mutations, insertions, and deletions. For the Consortium on von Willebrand Factor Mutations and Polymorphisms, and the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost. 1993 Feb 1;69(2):177–184. [PubMed] [Google Scholar]
  13. Groth C. G., Hathaway W. E., Gustafsson A., Geis W. P., Putnam C. W., Björkén C., Porter K. A., Starzl T. E. Correction of coagulation in the hemophilic dog by transplantation of lymphatic tissue. Surgery. 1974 May;75(5):725–733. [PMC free article] [PubMed] [Google Scholar]
  14. Halban P. A., Irminger J. C. Sorting and processing of secretory proteins. Biochem J. 1994 Apr 1;299(Pt 1):1–18. doi: 10.1042/bj2990001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hashemi S., Tackaberry E. S., Palmer D. S., Rock G., Ganz P. R. DDAVP-induced release of von Willebrand factor from endothelial cells in vitro: the effect of plasma and blood cells. Biochim Biophys Acta. 1990 Apr 9;1052(1):63–70. doi: 10.1016/0167-4889(90)90058-l. [DOI] [PubMed] [Google Scholar]
  16. Hattori R., Hamilton K. K., Fugate R. D., McEver R. P., Sims P. J. Stimulated secretion of endothelial von Willebrand factor is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein GMP-140. J Biol Chem. 1989 May 15;264(14):7768–7771. [PubMed] [Google Scholar]
  17. Hop C., Fontijn R., van Mourik J. A., Pannekoek H. Polarity of constitutive and regulated von Willebrand factor secretion by transfected MDCK-II cells. Exp Cell Res. 1997 Feb 1;230(2):352–361. doi: 10.1006/excr.1996.3431. [DOI] [PubMed] [Google Scholar]
  18. Journet A. M., Saffaripour S., Cramer E. M., Tenza D., Wagner D. D. von Willebrand factor storage requires intact prosequence cleavage site. Eur J Cell Biol. 1993 Feb;60(1):31–41. [PubMed] [Google Scholar]
  19. Kadhom N., Wolfrom C., Gautier M., Allain J. P., Frommel D. Factor VIII procoagulant antigen in human tissues. Thromb Haemost. 1988 Apr 8;59(2):289–294. [PubMed] [Google Scholar]
  20. Kaufman R. J. Biological regulation of factor VIII activity. Annu Rev Med. 1992;43:325–339. doi: 10.1146/annurev.me.43.020192.001545. [DOI] [PubMed] [Google Scholar]
  21. Kaufman R. J., Wasley L. C., Davies M. V., Wise R. J., Israel D. I., Dorner A. J. Effect of von Willebrand factor coexpression on the synthesis and secretion of factor VIII in Chinese hamster ovary cells. Mol Cell Biol. 1989 Mar;9(3):1233–1242. doi: 10.1128/mcb.9.3.1233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kaufman R. J., Wasley L. C., Dorner A. J. Synthesis, processing, and secretion of recombinant human factor VIII expressed in mammalian cells. J Biol Chem. 1988 May 5;263(13):6352–6362. [PubMed] [Google Scholar]
  23. Kroner P. A., Foster P. A., Fahs S. A., Montgomery R. R. The defective interaction between von Willebrand factor and factor VIII in a patient with type 1 von Willebrand disease is caused by substitution of Arg19 and His54 in mature von Willebrand factor. Blood. 1996 Feb 1;87(3):1013–1021. [PubMed] [Google Scholar]
  24. Kroner P. A., Friedman K. D., Fahs S. A., Scott J. P., Montgomery R. R. Abnormal binding of factor VIII is linked with the substitution of glutamine for arginine 91 in von Willebrand factor in a variant form of von Willebrand disease. J Biol Chem. 1991 Oct 15;266(29):19146–19149. [PubMed] [Google Scholar]
  25. Lethagen S. Desmopressin (DDAVP) and hemostasis. Ann Hematol. 1994 Oct;69(4):173–180. doi: 10.1007/BF02215950. [DOI] [PubMed] [Google Scholar]
  26. Lewis J. H., Bontempo F. A., Spero J. A., Ragni M. V., Starzl T. E. Liver transplantation in a hemophiliac. N Engl J Med. 1985 May 2;312(18):1189–1190. doi: 10.1056/NEJM198505023121812. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Liu L., Xia S., Seifert J. Transplantation of spleen cells in patients with hemophilia A. A report of 20 cases. Transpl Int. 1994 May;7(3):201–206. doi: 10.1007/BF00327088. [DOI] [PubMed] [Google Scholar]
  28. Mannucci P. M., Canciani M. T., Rota L., Donovan B. S. Response of factor VIII/von Willebrand factor to DDAVP in healthy subjects and patients with haemophilia A and von Willebrand's disease. Br J Haematol. 1981 Feb;47(2):283–293. doi: 10.1111/j.1365-2141.1981.tb02789.x. [DOI] [PubMed] [Google Scholar]
  29. Mannucci P. M. Desmopressin: a nontransfusional form of treatment for congenital and acquired bleeding disorders. Blood. 1988 Nov;72(5):1449–1455. [PubMed] [Google Scholar]
  30. Mazurier C., Meyer D. Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease--results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH. Thromb Haemost. 1996 Aug;76(2):270–274. [PubMed] [Google Scholar]
  31. Menache D., Aronson D. L., Darr F., Montgomery R. R., Gill J. C., Kessler C. M., Lusher J. M., Phatak P. D., Shapiro A. D., Thompson A. R. Pharmacokinetics of von Willebrand factor and factor VIIIC in patients with severe von Willebrand disease (type 3 VWD): estimation of the rate of factor VIIIC synthesis. Cooperative Study Groups. Br J Haematol. 1996 Sep;94(4):740–745. doi: 10.1046/j.1365-2141.1996.d01-1860.x. [DOI] [PubMed] [Google Scholar]
  32. Meyer D., Girma J. P. von Willebrand factor: structure and function. Thromb Haemost. 1993 Jul 1;70(1):99–104. [PubMed] [Google Scholar]
  33. Michnick D. A., Pittman D. D., Wise R. J., Kaufman R. J. Identification of individual tyrosine sulfation sites within factor VIII required for optimal activity and efficient thrombin cleavage. J Biol Chem. 1994 Aug 5;269(31):20095–20102. [PubMed] [Google Scholar]
  34. Moore H. P., Walker M. D., Lee F., Kelly R. B. Expressing a human proinsulin cDNA in a mouse ACTH-secreting cell. Intracellular storage, proteolytic processing, and secretion on stimulation. Cell. 1983 Dec;35(2 Pt 1):531–538. doi: 10.1016/0092-8674(83)90187-3. [DOI] [PubMed] [Google Scholar]
  35. Nishino M., Girma J. P., Rothschild C., Fressinaud E., Meyer D. New variant of von Willebrand disease with defective binding to factor VIII. Blood. 1989 Oct;74(5):1591–1599. [PubMed] [Google Scholar]
  36. Pittman D. D., Alderman E. M., Tomkinson K. N., Wang J. H., Giles A. R., Kaufman R. J. Biochemical, immunological, and in vivo functional characterization of B-domain-deleted factor VIII. Blood. 1993 Jun 1;81(11):2925–2935. [PubMed] [Google Scholar]
  37. Pittman D. D., Marquette K. A., Kaufman R. J. Role of the B domain for factor VIII and factor V expression and function. Blood. 1994 Dec 15;84(12):4214–4225. [PubMed] [Google Scholar]
  38. Pittman D. D., Millenson M., Marquette K., Bauer K., Kaufman R. J. A2 domain of human recombinant-derived factor VIII is required for procoagulant activity but not for thrombin cleavage. Blood. 1992 Jan 15;79(2):389–397. [PubMed] [Google Scholar]
  39. Scott J. P., Montgomery R. R. The rapid differentiation of type IIb von Willebrand's disease from platelet-type (pseudo-) von Willebrand's disease by the "neutral" monoclonal antibody binding assay. Am J Clin Pathol. 1991 Dec;96(6):723–728. doi: 10.1093/ajcp/96.6.723. [DOI] [PubMed] [Google Scholar]
  40. Sedlak B. J., Booyse F. M., Bell S., Rafelson M. E., Jr Comparison of two types of endothelial cells in long term culture. Thromb Haemost. 1976 Feb 29;35(1):167–177. [PubMed] [Google Scholar]
  41. Sporn L. A., Marder V. J., Wagner D. D. Differing polarity of the constitutive and regulated secretory pathways for von Willebrand factor in endothelial cells. J Cell Biol. 1989 Apr;108(4):1283–1289. doi: 10.1083/jcb.108.4.1283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Sporn L. A., Marder V. J., Wagner D. D. von Willebrand factor released from Weibel-Palade bodies binds more avidly to extracellular matrix than that secreted constitutively. Blood. 1987 May;69(5):1531–1534. [PubMed] [Google Scholar]
  43. Takeuchi M., Nagura H., Kaneda T. DDAVP and epinephrine-induced changes in the localization of von Willebrand factor antigen in endothelial cells of human oral mucosa. Blood. 1988 Sep;72(3):850–854. [PubMed] [Google Scholar]
  44. Vischer U. M., Wagner D. D. von Willebrand factor proteolytic processing and multimerization precede the formation of Weibel-Palade bodies. Blood. 1994 Jun 15;83(12):3536–3544. [PubMed] [Google Scholar]
  45. Vischer U. M., Wagner D. D. von Willebrand factor proteolytic processing and multimerization precede the formation of Weibel-Palade bodies. Blood. 1994 Jun 15;83(12):3536–3544. [PubMed] [Google Scholar]
  46. Voorberg J., Fontijn R., Calafat J., Janssen H., van Mourik J. A., Pannekoek H. Biogenesis of von Willebrand factor-containing organelles in heterologous transfected CV-1 cells. EMBO J. 1993 Feb;12(2):749–758. doi: 10.1002/j.1460-2075.1993.tb05709.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Wagner D. D. Cell biology of von Willebrand factor. Annu Rev Cell Biol. 1990;6:217–246. doi: 10.1146/annurev.cb.06.110190.001245. [DOI] [PubMed] [Google Scholar]
  48. Wagner D. D., Fay P. J., Sporn L. A., Sinha S., Lawrence S. O., Marder V. J. Divergent fates of von Willebrand factor and its propolypeptide (von Willebrand antigen II) after secretion from endothelial cells. Proc Natl Acad Sci U S A. 1987 Apr;84(7):1955–1959. doi: 10.1073/pnas.84.7.1955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Wagner D. D., Olmsted J. B., Marder V. J. Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells. J Cell Biol. 1982 Oct;95(1):355–360. doi: 10.1083/jcb.95.1.355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Wagner D. D., Saffaripour S., Bonfanti R., Sadler J. E., Cramer E. M., Chapman B., Mayadas T. N. Induction of specific storage organelles by von Willebrand factor propolypeptide. Cell. 1991 Jan 25;64(2):403–413. doi: 10.1016/0092-8674(91)90648-i. [DOI] [PubMed] [Google Scholar]
  51. Wagner D. D. The Weibel-Palade body: the storage granule for von Willebrand factor and P-selectin. Thromb Haemost. 1993 Jul 1;70(1):105–110. [PubMed] [Google Scholar]
  52. Webster W. P., Zukoski C. F., Hutchin P., Reddick R. L., Mandel S. R., Penick G. D. Plasma factor VIII synthesis and control as revealed by canine organ transplantation. Am J Physiol. 1971 May;220(5):1147–1154. doi: 10.1152/ajplegacy.1971.220.5.1147. [DOI] [PubMed] [Google Scholar]
  53. Wion K. L., Kelly D., Summerfield J. A., Tuddenham E. G., Lawn R. M. Distribution of factor VIII mRNA and antigen in human liver and other tissues. Nature. 1985 Oct 24;317(6039):726–729. doi: 10.1038/317726a0. [DOI] [PubMed] [Google Scholar]
  54. Wise R. J., Dorner A. J., Krane M., Pittman D. D., Kaufman R. J. The role of von Willebrand factor multimers and propeptide cleavage in binding and stabilization of factor VIII. J Biol Chem. 1991 Nov 15;266(32):21948–21955. [PubMed] [Google Scholar]
  55. Zelechowska M. G., van Mourik J. A., Brodniewicz-Proba T. Ultrastructural localization of factor VIII procoagulant antigen in human liver hepatocytes. Nature. 1985 Oct 24;317(6039):729–730. doi: 10.1038/317729a0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES